» Articles » PMID: 31742639

Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015

Overview
Specialty Oncology
Date 2019 Nov 20
PMID 31742639
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Squamous cell carcinoma of the anus (SCCA) incidence is rising in the United States. Study of incidence trends by stage at diagnosis, age-specific and birth cohort patterns, and trends in mortality could provide evidence for a true increase and etiological clues for the increase in incidence.

Methods: Using the US Cancer Statistics dataset, we examined trends in SCCA incidence (2001-2015) and mortality (2001-2016) rates. Join-point regression was used to compute annual and average annual percentage change (AAPC). Incidence patterns by 5-year age group and birth cohort were evaluated using incidence rate ratios (IRRs) and age-period-cohort modeling.

Results: SCCA incidence increased 2.7% per year (95% confidence interval [CI] = 2.1% to 3.3%), with pronounced increases in age groups 50 years and older. Distant-stage SCCA incidence tripled (AAPC = 8.6%, 95% CI = 5.4% to 12.0%, among men and AAPC = 7.5%, 95% CI = 4.8% to 10.2%, among women) and regional-stage SCCA incidence nearly doubled (AAPC = 4.7% for men and women) in both sexes; the AAPC for localized stage was 1.3% (95% CI = 0.6% to 2.0%) in men and 2.3% (95% CI = 1.8% to 2.8%) in women. Compared with adults born circa 1946, recently born black men (born circa 1986) had a nearly fivefold higher risk (IRR = 4.7, 95% CI = 2.1 to 10.2) of SCCA, and the risk doubled among white men (IRR = 2.0, 95% CI = 1.7 to 2.2) and white women (IRR = 2.1, 95% CI = 1.9 to 2.3) born after circa 1960. Anal cancer mortality rates increased 3.1% per year (95% CI = 2.6% to 3.5%) with statistically significant increases in age groups 50 years and older. SCCA incidence-based mortality increased 1.9% annually (95% CI = 0.5% to 3.4%), with a notable (4.9%, 95% CI = 2.4% to 7.3%, per year) rise in adults ages 60-69 years.

Conclusion: The increase in SCCA incidence, particularly advanced-stage disease, and a similar increase in mortality suggest a true increase in the occurrence of SCCA. Future research and improved prevention are urgently needed to mitigate the increasing disease burden.

Citing Articles

The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal Cancer.

Bhamidipati D, Johnson J, Lin K, Pelicano H, Eng C, Huey R Cancers (Basel). 2025; 17(2.

PMID: 39858090 PMC: 11764299. DOI: 10.3390/cancers17020308.


Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence.

Kabarriti R, Lloyd S, Jabalee J, Del Vecchio Fitz C, Tao R, Slater T Cancers (Basel). 2025; 17(2).

PMID: 39857955 PMC: 11764359. DOI: 10.3390/cancers17020174.


Trends in the Disease Burden and Risk Factors of Women's Cancers in China From 1990 to 2019.

Ning W, Liu J, Lu Y, Zhu B, Zhang W, Mao Y Int J Public Health. 2024; 69:1607245.

PMID: 39698306 PMC: 11652174. DOI: 10.3389/ijph.2024.1607245.


Prevalence of HPV in anal cancer: exploring the role of infection and inflammation.

Ebrahimi F, Rasizadeh R, Jafari S, Baghi H Infect Agent Cancer. 2024; 19(1):63.

PMID: 39696546 PMC: 11654204. DOI: 10.1186/s13027-024-00624-0.


Interstitial HDR brachytherapy for anal cancer-results and quality of life.

Jirkovska M, Stankusova H, Kindlova A, Jirkovsky D, Lohynska R Strahlenther Onkol. 2024; .

PMID: 39542884 DOI: 10.1007/s00066-024-02316-5.


References
1.
Palefsky J . Practising high-resolution anoscopy. Sex Health. 2013; 9(6):580-6. DOI: 10.1071/SH12045. View

2.
Lin C, Slama J, Gonzalez P, Goodman M, Xia N, Kreimer A . Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. Lancet Infect Dis. 2019; 19(8):880-891. PMC: 6656696. DOI: 10.1016/S1473-3099(19)30164-1. View

3.
Shiels M, Copeland G, Goodman M, Harrell J, Lynch C, Pawlish K . Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients. Cancer. 2015; 121(12):2063-71. PMC: 4470321. DOI: 10.1002/cncr.29324. View

4.
Hoots B, Palefsky J, Pimenta J, Smith J . Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009; 124(10):2375-83. DOI: 10.1002/ijc.24215. View

5.
Van Dyne E, Henley S, Saraiya M, Thomas C, Markowitz L, Benard V . Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2018; 67(33):918-924. PMC: 6107321. DOI: 10.15585/mmwr.mm6733a2. View